Meyo et al. in NSCLC and Ugurel et al. found in melanoma that higher sPD-1 level patients had shorter PFS, whereas Incorvaia et al. found the opposite result in metastatic RCC [38, 42, 46]. This evidence concerns the gene HOXD13 and non-small cell lung carcinoma.